IL17A and type 1 diabetes mellitus: Since IFN-γ and IL-17-mediated pro-inflammatory pathways play a key role in β-cell deletion, blockage of the secretion of IFN-γ and IL-17 helps to delay or reverse the pathogenesis of T1D (25).